Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach
Open Access
- 12 November 2022
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 21 (1) , 1-12
Abstract
Background: Nonalcoholic fatty liver disease is associated with an increased cardiovascular disease (CVD) risk, although the exact mechanism(s) are less clear. Moreover, the relationship between newly redefined metabolic-associated fatty liver disease (MAFLD) and CVD risk has been poorly investigated. Data-driven machine learning (ML) techniques may be beneficial in discovering the most important risk factors for CVD in patients with MAFLD. Methods: In this observational study, the patients with MAFLD underwent subclinical atherosclerosis assessment and blood biochemical analysis. Patients were split into two groups based on the presence of CVD (defined as at least one of the following: coronary artery disease; myocardial infarction; coronary bypass grafting; stroke; carotid stenosis; lower extremities artery stenosis). The ML techniques were utilized to construct a model which could identify individuals with the highest risk of CVD. We exploited the multiple logistic regression classifier operating on the most discriminative patient’s parameters selected by univariate feature ranking or extracted using principal component analysis (PCA). Receiver operating characteristic (ROC) curves and area under the ROC curve (AUC) were calculated for the investigated classifiers, and the optimal cut-point values were extracted from the ROC curves using the Youden index, the closest to (0, 1) criteria and the Index of Union methods. Results: In 191 patients with MAFLD (mean age: 58, SD: 12 years; 46% female), there were 47 (25%) patients who had the history of CVD. The most important clinical variables included hypercholesterolemia, the plaque scores, and duration of diabetes. The five, ten and fifteen most discriminative parameters extracted using univariate feature ranking and utilized to fit the ML models resulted in AUC of 0.84 (95% confidence interval [CI]: 0.77–0.90, p < 0.0001), 0.86 (95% CI 0.80–0.91, p < 0.0001) and 0.87 (95% CI 0.82–0.92, p < 0.0001), whereas the classifier fitted over 10 principal components extracted using PCA followed by the parallel analysis obtained AUC of 0.86 (95% CI 0.81–0.91, p < 0.0001). The best model operating on 5 most discriminative features correctly identified 114/144 (79.17%) low-risk and 40/47 (85.11%) high-risk patients. Conclusion: A ML approach demonstrated high performance in identifying MAFLD patients with prevalent CVD based on the easy-to-obtain patient parameters.Keywords
Funding Information
- Medical University of Silesia (KNW-1-007/N/8/K)
- Silesia University of Technology (Grant for developing and maintaining research potential)
This publication has 57 references indexed in Scilit:
- Aortic Pulse Wave Velocity Improves Cardiovascular Event PredictionJACC, 2014
- High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetesDiabetologia, 2012
- Analytical performance evaluation of the Cobas 6000 analyzer – special emphasis on trueness verificationClinical Chemistry and Laboratory Medicine (CCLM), 2008
- Comparison and evaluation of two C‐reactive protein assays based on particle‐enhanced immunoturbidimetryJournal of Clinical Laboratory Analysis, 2007
- Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal, 2005
- Corrections: Nonalcoholic steatohepatitis: Summary of an AASLD single topic conferenceHepatology, 2003
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic ConferenceHepatology, 2003
- Glycated Hemoglobin Standardization – National Glycohemoglobin Standardization Program (NGSP) PerspectiveClinical Chemistry and Laboratory Medicine (CCLM), 2003
- Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up ExperienceAnnals of Internal Medicine, 1961